
Feline Tumors Reveal Shared Cancer Genes, Boosting Drug Efficacy
A major 2026 study published in Science reveals that cats share critical cancer-driving gene mutations with humans at nearly identical rates, particularly the TP53 gene. By sequencing DNA from nearly 500 feline tumors across 13 cancer types, researchers found that cats are superior models for human oncology compared to mice due to shared environmental exposures. The study identified FBXW7 as a key driver in feline breast cancer, which also affects aggressive human breast cancers, and showed that specific chemotherapy drugs work better against cells with this mutation. Additionally, feline skin cancers showed UV damage signatures similar to human melanomas, reinforcing the 'One Health' approach to treating shared biological challenges.











